HsuWC, LauKHK, HuangR, GhiloniS, LeH, GilroyS, AbrahamsonM, MooreJ: Utilization of a cloud-based diabetes management program for insulin initiation and titration enables collaborative decision making between healthcare providers and patients. Diabetes Technol Ther, 2016; 18:59–67.
2.
The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long term complications in the diabetes control in insulin dependent diabetes mellitus. N Engl J Med, 1993; 329:977–986.
3.
NathanDM, BaylessM, ClearyP, GenuthS, Gubitosi-KlugR, LachinJM, LorenziG, ZinmanB; the DCCT/EDIC Research Group: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 years: advances and contributions. Diabetes, 2013; 62:3976–3986.
4.
RiddleMC, RosenstockJ, GerichJ; the Insulin Glargine 4002 Study Investigators: The Treat-to-Target Trial. Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care, 2003; 26:3080–3086.
5.
HaywardRA, ManningWG, KaplanSH, WagnerEH, GreenfieldS: Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization. JAMA, 1997; 278:1663–1669.
6.
SwinnenSGHA, DeVriesJH: Contact frequency determines outcome of basal insulin initiation trials in type 2 diabetes. Diabetologia, 2009; 52:2324–2327.
7.
PalK, EastwoodSV, MichieS, FarmerAJ, BarnardML, PeacockR, WoodB, InnissJD, MurrayE: Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev, 2013; 3:CD008776.
8.
CharpentierG, BenhamouPY, DardariD, ClergeotA, FrancS, Schaepelynck-BelicarP, CatargiB, MelkiV, ChaillousL, FarretA, BossonJL, PenfornisA; TeleDiab Study Group: The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study). Diabetes Care, 2011; 34:533–539.
9.
FrancS, BorotS, RonsinO, QuesadaJL, DardariD, FagourC, RenardE, LeguerrierAM, VigeralC, MoreauF, WiniszewskiP, VambergueA, Mosnier-PudarH, KesslerL, ReffetS, GuerciB, MillotL, HalimiS, ThivoletC, BenhamouPY, PenfornisA, CharpentierG, HanaireH: Telemedicine and type 1 diabetes: is technology per se sufficient for to improve glycaemic control?. Diabetes Metab, 2013; 40:61–66.
10.
RenardE, CobelliC, ZisserHC, KovatchevBP: Artificial pancreas goes outpatient: a new diabetes ecosystem. J Diabetes Sci Technol, 2013; 7:1411–1415.
11.
CobelliC, RenardE, KovatchevB: The artificial pancreas: a digital-age treatment for diabetes. Lancet Diabetes Endocrinol, 2014; 2:679–681.
